In vitro evaluation of bioadhesive films containing ibuprofen

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 10, Issue 3, 2011, Pages 240-245

  Padula, C ^a   Nicoli, S ^a   Santi, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Bioadhesive film; Ibuprofen; Skin permeation

Indexed keywords

2 PYRROLIDINONE; IBUPROFEN; MENTHOL; POLYVINYL DERIVATIVE; PROPYLENE GLYCOL; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; IN VITRO STUDY; NONHUMAN; REVIEW;

EID: 79960615045     PISSN: 18715230     EISSN: 1875614X     Source Type: Journal    
DOI: 10.2174/1871523011109030240     Document Type: Review

References (26)

1. Vane, J.R.; Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature, 1971, 231, 232-235.
2. Cashman, J.N.; The mechanism of action of NSAIDs in analgesia. Drugs, 1996, 52(Suppl 5), 13-23.
3. [Vane, J.R., Botting, R.M.; Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med, 1998, 104(3A), 2S-8S.
4. Rainsford, K.D.; Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology, 2009, 17(6), 275-342.
5. Trnavsky, K., Fischer, M., Vogtle-Junkert, U., Schreyger, F.; Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthitis. Results of a randomized, double-blind, placebo controlled study. J Rheumatol, 2004, 31(3), 565-572.
6. Underwood, M., Ashby, D., Cross, P., Hennessy, E., Letley, L., Martin, J., Mt-Isa, S., Parson, S., Vickers, M., Whyte, K.; Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ, 2008, 336(7636), 138-142.
7. Prausnitz, M.R., Mitragotri, S., Langer, R.; Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov, 2004, 3, 115-124.
8. Chien, Y.W. In: Controlled drug delivery Fundamentals and applications; Robinson JR, Lee VHL, Eds.; Marcel Dekker: New York, 1987; p. 523-552.
9. Colombo, P., Catellani, P., Padula, C., Santi, P., Colombo, G. Film for active ingredients for dermal and transdermal administration, patent WO200230402, 18 April 2002.
10. Padula, C., Nicoli, S., Aversa, V., Colombo, P., Falson, F., Pirot, F., Santi, P.; Bioadhesive film for dermal and transdermal drug delivery. Eur J Dermatol, 2007, 17(4), 309-312.
11. Beetge, E., Du Plessis, J., Muller, D.G., Goosen, C., Van Rensburg, F.J.; The influence of the physicochemical characteristics and pharmacokinetics properties of selected NSAID's on their transdermal absorption. Int J Pharm, 2000, 193, 261-264.
12. Dick, I., Scott, R.; Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol, 1992, 44, 640-645.
13. Jacobi, U., Kaiser, M., Toll, R., Mangelsdorf, S., Audring, H., Otberg, N., Sterry, W., Lademann, J.; Porcine ear skin: an in vitro model for human skin. Skin Res Technol, 2007, 13(1), 19-24.
14. Sekkat, N., Kalia, Y., Guy, R.; Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci 2002, 91(11), 2376-2381.
15. Padula, C., Colombo, G., Nicoli, S., Catellani, P., Massimo, G., Santi, P.; Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release, 2003, 88, 277-285.
16. Padula, C., Nicoli, S., Colombo, P., Santi, P.; Single-layer transdermal film containing lidocaine: Modulation of drug release. Eur J Pharm Biopharm, 2007, 66(3), 422-428.
17. Nicoli, S., Colombo, P., Santi, P.; Release and permeation kinetics of caffeine from bioadhesive transdermal films. AAPS J, 2005, 7, E218-E223.
18. Femenia-Font, A., Padula, C., Marra, F., Balaguer-Fernandez, C., Merino, V., Lopez-Castellano, A., Nicoli, S., Santi, P.; Bioadhesive monolayer film for the in vitro trasndermal delivery of sumatriptan. J Pharm Sci, 2006, 95, 1561-1569.
19. Padula, C., Chiapponi, C., DiBari, M.T., Deriu, A., Sonvico, F., Barbieri, S., Ollivier, J., Santi, P.; Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering. J Pharm Sci, 2010, 99(10), 4277-4284.
20. Gonzalez, N., Sumano, H.; Design of two liquid ibuprofenpoloxamer- limonene or menthol preparations for dermal administration. Drug Deliv, 2007, 14(5), 287-293.
21. Brain, K.R., Green, D.M., Dykes, P.J., Marks, R., Bola, T.S.; The role of menthol in skin penetrtion from topical formulations if ibuprofen 5% in vivo. Skin Pharmacol Physiol, 2006, 19(1), 17-21.
22. Bucks, D., Maibach, H.I. In: Percutaneous absorption Drugscosmetics- mechanisms-methodology; Bronaugh R, Maibach HI, editors; Marcel Dekker: New York, 1999; p. 81-105.
23. Zhai, H., Maibach, H.I.; Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Physiol, 2001, 14, 1-10.
24. Zhai, H., Maibach, H.I.; Occlusion vs. skin barrier function. Skin Res Technol, 2002, 8(1), 1-6.
25. Blank, I.H. In: Percutaneous absorption Mechanismsmethodology- drug delivery; Bronaugh R, Maibach HI, Eds.; Marcel Dekker: New York, 1985.
26. Nicoli, S., Penna, E., Padula, C., Colombo, P., Santi, P.; New transdermal bioadhesive film containing oxybutynin: in vitro permeation across rabbit ear skin. Int J Pharm, 2006, 325(1-2), 2-7.